No Mugs, but What About Those Fees

Info Document Actions Print this The Sunday New York Times editorialized that the corruption exposed between the psychiatric profession and the drug industry must end. No Mugs, but What About Those Fees Date Published: Jan 03, 2009 07:00 PM Author: Editorial Source: The New York Times New pharmaceutical industry guidelines should stop most drug companies…

Expert or Shill?

Info Document Actions Print this The New York Times editorial board weighs in on the corruption in the psychiatric industry exposed by recent USA Congressional investigations. Expert or Shill? Date Published: Nov 30, 2008 01:00 AM Author: Editorial Source: The New York Times original article: http://www.nytimes.com/2008/11/30/opinion/30sun2.html The New York Times – Editorial More evidence has…

Research Center Tied to Drug Company

Info Document Actions Print this Further reports from The New York Times about how a Congressional investigation revealed that psychiatrist Dr. Joseph Biederman misused the name of his institution — Harvard — to fraudulently promote the massive use of the psychiatric drgus known as neuroleptics or antipsychotics. Research Center Tied to Drug Company Date Published:…

Researchers Fail to Reveal Full Drug Pay

The Sunday New York Times (8 June 2008) reports about a world-famous Harvard psychiatrist who is considered a catalyst for the enormous increase in psychiatric drugging of kids. Times claims that US Congressional investigators discovered Harvard’s Dr. Joseph Biederman did not disclose to Harvard authorities, as required by law, much of the more than a…

Sunday New York Times on Congressional investigation of Harvard psychiatrist

Info Sunday New York Times on Congressional investigation of Harvard psychiatrist US Senator Charles E. Grassley helped investigate corruption by the psychiatric drug industry. His investigation revealed that Harvard psychiatrist Dr. Joseph Biederman had illegally covered up much of more than a million dollars he had received from the psychiatric drug industry. Dr. Biederman is…

House Lawmaker Seeks Data From Makers of Stents and Drugs

Info Document Actions Print this Congressman Henry Waxman (D-Calif.) is looking into allegations of inappropriate marketing of Zyprexa and other drugs and medical devices, according to Reuters. Waxman is the chairman of a house committee investigating off-label drug marketing by Eli Lilly & Company, AstraZeneca and Cephalon. Off-label use occurs when doctors prescribe products for…